908 DevicesMASS
MASS
About: 908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
Employees: 246
0
Funds holding %
of 7,296 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
150% more capital invested
Capital invested by funds: $36.9M [Q4 2024] → $92.3M (+$55.4M) [Q1 2025]
100% more funds holding in top 10
Funds holding in top 10: 1 [Q4 2024] → 2 (+1) [Q1 2025]
58% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 19
44% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 16
10.25% more ownership
Funds ownership: 48.12% [Q4 2024] → 58.37% (+10.25%) [Q1 2025]
7% more funds holding
Funds holding: 81 [Q4 2024] → 87 (+6) [Q1 2025]
31% less call options, than puts
Call options by funds: $336K | Put options by funds: $487K
Research analyst outlook
We haven’t received any recent analyst ratings for MASS.
Financial journalist opinion
Based on 4 articles about MASS published over the past 30 days
Neutral
Business Wire
1 week ago
Metropolitan Washington Council of Governments Adds 908 Devices' XplorIR to Its Hazardous Materials Response Toolkit
BOSTON--(BUSINESS WIRE)-- #chemID--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that the Metropolitan Washington Council of Governments (COG) has purchased eight XplorIR devices, one for each of the seven counties and District of Columbia, which comprise the COG. The devices were shipped in Q1 2025, with training taking place in Q2 2025. The handheld XplorIR device accurately detects, identifies, and quantifies 5,000 unknown gas and vapor c.
Positive
The Motley Fool
2 weeks ago
Why 908 Devices Stock Rocketed More Than 18% Higher This Week
A deal agreed in a far-off country was the spark that ignited chemical analysis device maker 908 Devices (MASS -2.56%) this week. The company's stock burned hot, finishing the period over 18% higher in price, according to data compiled by S&P Global Market Intelligence.
Positive
Zacks Investment Research
2 weeks ago
All You Need to Know About 908 Devices (MASS) Rating Upgrade to Buy
908 Devices (MASS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Neutral
Business Wire
3 weeks ago
908 Devices to Participate in the William Blair 45th Annual Growth Stock Conference
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will participate in the upcoming William Blair 45th Annual Growth Stock Conference. 908 Devices' management is scheduled to present on Wednesday, June 4 at 4 p.m. Central Time / 5 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on th.
Neutral
Seeking Alpha
1 month ago
908 Devices Inc. (MASS) Q1 2025 Earnings Call Transcript
908 Devices Inc. (NASDAQ:MASS ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Kelly Gura - Investor Relations Kevin Knopp - Chief Executive Officer & Co-Founder Joe Griffith - Chief Financial Officer Conference Call Participants Matt Larew - William Blair Dan Arias - Stifel Puneet Souda - Leerink Partners Brendan Smith - TD Cowen Operator Hello and welcome everyone to the 908 Devices First Quarter 2025 Financial Results Conference Call. My name is Becky [ph] and I'll be your operator today.
Positive
Zacks Investment Research
1 month ago
Bet On 4 Low-Beta Stocks BWB, LRN, MASS & PM Despite Tariff Truce
It is imperative to build a portfolio of low-beta stocks in a volatile market. Bridgewater Bancshares, Stride, 908 Devices, and Philip Morris are well-positioned to gain.
Negative
Zacks Investment Research
1 month ago
908 Devices Inc. (MASS) Reports Q1 Loss, Misses Revenue Estimates
908 Devices Inc. (MASS) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.33 per share a year ago.
Neutral
Business Wire
1 month ago
908 Devices Reports First Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS) a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended March 31, 2025. “We are off to a strong start in 2025, with first-quarter revenue exceeding our expectations and the transformation to 908 Devices 2.0 already delivering both top-line growth and meaningful cost reductions,” said Kevin J. Kno.
Negative
Zacks Investment Research
1 month ago
908 Devices Inc. (MASS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
908 Devices (MASS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Neutral
Business Wire
1 month ago
908 Devices Equips rescEU Disaster Preparedness Reserve with Advanced Chemical Detection
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announced that its devices for rapid chemical detection at the point of need are being included in strategic stockpiles within Europe as part of rescEU, an EU-funded project that is establishing a reserve of disaster response capabilities. These reserves include stockpiles of chemical, biological, radiation and nuclear (CBRN) capabilities for detection, sampling, identifi.
Charts implemented using Lightweight Charts™